002219.SZ
新里程
SZSE · Healthcare · Q 卫生 · CN
CNY 2.13
−4.48%Year over year
Reported trailing growth
- Revenue
- -18.3%
- EBITDA
- —
- EBIT
- -49.9%
- EPS
- -75.6%
- Free cash flow
- +215.9%
- Operating cash flow
- -16.3%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -1.2%
- EBITDA
- -8.7%
- EBIT
- -23.3%
- Net income
- -41.7%
- EPS
- -41.8%
- Free cash flow
- -7.5%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026